Aspirin enhances platelet isoprostanes in type 2 diabetes

March 23, 2012
Aspirin enhances platelet isoprostanes in type 2 diabetes
For patients with type 2 diabetes mellitus who are treated with aspirin, isoprostanes are overproduced, which is linked with enhanced platelet recruitment, according to a study published online March 16 in Diabetes.

(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) who are treated with aspirin, isoprostanes are overproduced, which is linked with enhanced platelet recruitment, according to a study published online March 16 in Diabetes.

Noting that aspirin has a modest influence on in T2DM, Roberto Cangemi, M.D., Ph.D., from the Sapienza University of Rome, and colleagues investigated the effect of aspirin on platelet isoprostanes in patients with T2DM. Fifty aspirin-treated and 50 untreated T2DM patients were compared with 100 patients without diabetes, matched for age, gender, atherosclerosis , and aspirin treatment. In 36 aspirin-free patients, with and without diabetes, a seven-day treatment with aspirin was performed.

The researchers found that in patients with diabetes versus those without, and in aspirin-treated versus untreated , higher platelet recruitment, platelet isoprostane, and activation of the catalytic subunit of reduced NAD phosphate oxidase (NOX2) were seen. In all aspirin-treated patients, platelet thromboxane (Tx) A2 was inhibited. In those with and without diabetes, aspirin inhibited platelet TxA2 similarly in the interventional study. A parallel increase was seen in platelet recruitment, isoprostane levels, and NOX2 activation in patients with diabetes, whereas no change was seen in those without diabetes.

"We provide evidence that, in T2DM patients, low-dose aspirin enhances platelet isoprostanes as a consequence of NOX2-generated reactive oxidant species upregulation," the authors write. "This effect mitigates the antiplatelet effect of aspirin and may account for its lower clinical efficacy in T2DM compared with other atherosclerotic settings."

Explore further: Aspirin may be less effective heart treatment for women than men

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Aspirin resistant proteins are identified

June 26, 2007

Spanish scientists have identified blood proteins that might create aspirin resistance that keeps thousands of people from reaping aspirin's benefits.

Aspirin may lower the risk of pancreatic cancer

April 4, 2011

The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here ...

Recommended for you

Diets avoiding dry-cooked foods can protect against diabetes

August 24, 2016

Simple changes in how we cook could go a long way towards preventing diabetes, say researchers at the Icahn School of Medicine at Mount Sinai. A new randomized controlled trial, published online July 29 in the journal Diabetologia, ...

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.